A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

NCT05071729 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions

DRUG: Elinzanetant (BAY3427080)

Sponsor

Bayer